Platform Evaluation
2 articles

Bio & Health Tech
How to Evaluate an AI Drug Discovery Platform When No One Keeps Score
Evaluating AI drug discovery platforms requires a structured approach, focusing on specific AI specialization, reproducible validation evidence, and clinical translation rather than relying on unreliable, non-standardized benchmarks.
Sofia Rodriguez·November 18, 2026

Bio & Health Tech
Why You Can't Rank AI Drug Discovery Platforms by Success Rate — and the Framework That Actually Works
Evaluating AI drug discovery platforms by success rate is impossible due to a lack of standardized metrics. Instead, compare platforms based on their business models, data strategies, and the structure of their pharmaceutical partnerships.
Aisha Khan·November 1, 2026
